Evaluation of fetal thymus size in maternal autoimmune diseases : systemic lupus erythematosus, Sjögren's syndrome and antiphospholipid antibody syndrome
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
PURPOSE: To investigate the effect of inflammation on the fetal thymus-thoracic ratio (TTR) in pregnant women with systemic lupus erythematosus (SLE), Sjögren's syndrome (SS) and antiphospholipid antibody syndrome (APS).
METHOD: This prospective case-control study included 45 pregnant women with SLE, SS, and APS and 90 gestational age-matched healthy pregnant women between 24 and 37 gestational weeks. The ratio of the anteroposterior fetal thymus length to the transverse mediastinal length was calculated as the TTR in the study groups.
RESULTS: Fetal TTR was significantly lower in the case group (p < 0.001). Fetal TTR in the APS group was significantly lower than SS group (p = 006). The patients using hydroxychloroquine (HCQ) had significantly higher fetal TTR compared to patients not using HCQ (p = 0.004). A moderate negative correlation was found between the disease duration and fetal TTR (r = - 0.552, p < 0.001). In predicting admission to the neonatal intensive unit care (NICU), a value of 0.31 was found for the fetal TTR with a sensitivity of 83.3% and a specificity of 69% CONCLUSION: Maternal inflammation in pregnancies with autoimmune diseases may affect the intrauterine milieu of the fetus and cause a lower fetal TTR. Additionally, the lower level of fetal TTR may be more effective and beneficial for the clinician if combined with other risk factors in predicting NICU admission.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:309 |
|---|---|
| Enthalten in: |
Archives of gynecology and obstetrics - 309(2024), 4 vom: 28. Apr., Seite 1421-1427 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Uyan Hendem, Derya [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 26.02.2024 Date Revised 13.05.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00404-023-07035-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35542438X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35542438X | ||
| 003 | DE-627 | ||
| 005 | 20240513232051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00404-023-07035-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1406.xml |
| 035 | |a (DE-627)NLM35542438X | ||
| 035 | |a (NLM)37037914 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Uyan Hendem, Derya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of fetal thymus size in maternal autoimmune diseases |b systemic lupus erythematosus, Sjögren's syndrome and antiphospholipid antibody syndrome |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2024 | ||
| 500 | |a Date Revised 13.05.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a PURPOSE: To investigate the effect of inflammation on the fetal thymus-thoracic ratio (TTR) in pregnant women with systemic lupus erythematosus (SLE), Sjögren's syndrome (SS) and antiphospholipid antibody syndrome (APS) | ||
| 520 | |a METHOD: This prospective case-control study included 45 pregnant women with SLE, SS, and APS and 90 gestational age-matched healthy pregnant women between 24 and 37 gestational weeks. The ratio of the anteroposterior fetal thymus length to the transverse mediastinal length was calculated as the TTR in the study groups | ||
| 520 | |a RESULTS: Fetal TTR was significantly lower in the case group (p < 0.001). Fetal TTR in the APS group was significantly lower than SS group (p = 006). The patients using hydroxychloroquine (HCQ) had significantly higher fetal TTR compared to patients not using HCQ (p = 0.004). A moderate negative correlation was found between the disease duration and fetal TTR (r = - 0.552, p < 0.001). In predicting admission to the neonatal intensive unit care (NICU), a value of 0.31 was found for the fetal TTR with a sensitivity of 83.3% and a specificity of 69% CONCLUSION: Maternal inflammation in pregnancies with autoimmune diseases may affect the intrauterine milieu of the fetus and cause a lower fetal TTR. Additionally, the lower level of fetal TTR may be more effective and beneficial for the clinician if combined with other risk factors in predicting NICU admission | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antiphospholipid antibody syndrome | |
| 650 | 4 | |a Fetal thymus-thoracic ratio | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a Sjögren’s syndrome | |
| 650 | 4 | |a Systemic lupus erythematosus | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Oluklu, Deniz |e verfasserin |4 aut | |
| 700 | 1 | |a Menekse Beser, Dilek |e verfasserin |4 aut | |
| 700 | 1 | |a Yildirim, Muradiye |e verfasserin |4 aut | |
| 700 | 1 | |a Tugrul Ersak, Duygu |e verfasserin |4 aut | |
| 700 | 1 | |a Tanacan, Atakan |e verfasserin |4 aut | |
| 700 | 1 | |a Sahin, Dilek |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of gynecology and obstetrics |d 1995 |g 309(2024), 4 vom: 28. Apr., Seite 1421-1427 |w (DE-627)NLM012938351 |x 1432-0711 |7 nnns |
| 773 | 1 | 8 | |g volume:309 |g year:2024 |g number:4 |g day:28 |g month:04 |g pages:1421-1427 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00404-023-07035-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 309 |j 2024 |e 4 |b 28 |c 04 |h 1421-1427 | ||